Cost-effectiveness analysis of the use of palivizumab in the prophylaxis of preterm patients in Mexico Análisis de costo-efectividad del uso de palivizumab en la profilaxis de pacientes prematuros en México

• Main Authors: Guillermo Salinas-Escudero (Author), Silvia Martínez-Valverde (Author), Alfonso Reyes-López (Author), Juan Garduño-Espinosa (Author), Onofre Muñoz-Hernández (Author), Víctor Granados-García (Author), Kely Rely (Author)
• Format: Book
• Published: Instituto Nacional de Salud Pública, 2012-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

OBJECTIVE: The study evaluated the incremental cost-effectiveness ratio (ICER) of the prophylaxis of palivizumab, for the reduction of complications associated to the respiratory syncytial virus in preterm patients in Mexico. MATERIAL AND METHODS: A decision tree was developed in preterm groups [<...